Ibironke G F, Saba O J
Department of Physiology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Afr J Med Med Sci. 2006 Dec;35(4):443-5.
The effect exerted by hyperglycemia on the analgesic potential of morphine was studied in female Wistar rats with the hotplate device and the formalin test. Hyperglycemia induced by an intraperitoneal (ip) injection of alloxan (40mg/Kg) significantly (p < 0.05) reduced the potency of morphine in the two tests employed. While morphine caused an inhibition of 48.64% (44.83 +/- 3.69s vs 30.16 +/- 4.12s) in the pain sensitivity of control non-diabetic animals using the hotplate device, an inhibition of only 36.25% (31.50 +/- 2.28s Vs 23.12 +/- 1.80s) was recorded in the pain sensitivity of the diabetic group using the same method. In the formalin test, morphine inhibited the pain sensitivity by 35.23% (1.93 +/- 0.17 Vs 1.25 +/- 0.21) in the control non diabetic group and by 25.93% (2.16 +/- 0.09 Vs 160 +/- 0.15) in the diabetic group. From these data, it is hypothesized that the hyperglycemic state is responsible for selectively affecting the potency of morphine. These results, if found to be true in man, may have clinical implications for the use of morphine in diabetic subjects.
利用热板装置和福尔马林试验,在雌性Wistar大鼠中研究了高血糖对吗啡镇痛潜力的影响。腹腔注射四氧嘧啶(40mg/Kg)诱导的高血糖显著(p<0.05)降低了吗啡在两种所用试验中的效力。在使用热板装置时,吗啡对对照非糖尿病动物的疼痛敏感性产生了48.64%的抑制作用(44.83±3.69秒对30.16±4.12秒),而使用相同方法时,糖尿病组的疼痛敏感性仅记录到36.25%的抑制作用(31.50±2.28秒对23.12±1.80秒)。在福尔马林试验中,吗啡对对照非糖尿病组的疼痛敏感性抑制了35.23%(1.93±0.17对1.25±0.21),对糖尿病组的疼痛敏感性抑制了25.93%(2.16±0.09对1.60±0.15)。根据这些数据,推测高血糖状态是选择性影响吗啡效力的原因。如果这些结果在人类中得到证实,可能对糖尿病患者使用吗啡具有临床意义。